SECOND AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT DATED JANUARY 31, 1995 between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and CYGNUS, INC. for DEVICE FOR IONTOPHORETIC NON-INVASIVE SAMPLING OR DELIVERY OF SUBSTANCES UC Agreement Control Number...Confidential Treatment • November 13th, 2002 • Cygnus Inc /De/ • Measuring & controlling devices, nec
This second amendment, (“Second Amendment”) is effective this 19th day of September, 2002 (“Effective Date”), by and between The Regents of the University of California, a California corporation, having its administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 (“The Regents”), and Cygnus, Inc., a Delaware corporation having its principal place of business at 400 Penobscot Drive, Redwood City, California 94063, formerly known as Cygnus Therapeutic Systems, a California corporation (“Licensee”).
SALES, MARKETING AND DISTRIBUTION AGREEMENTSales, Marketing and Distribution Agreement • November 13th, 2002 • Cygnus Inc /De/ • Measuring & controlling devices, nec • California
THIS SALES, MARKETING AND DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into as of July 8, 2002, by and between CYGNUS, INC., a Delaware corporation with its principal place of business at 400 Penobscot Drive, Redwood City, California 94063 (“Cygnus”) and SANKYO PHARMA INC., a Delaware corporation with its place of business at Two Hilton Court, Parsippany, New Jersey 07054 (“Sankyo”). Cygnus and Sankyo are referred to herein individually as a “party” and collectively as the “parties.”
